FibroBiologics (FBLG) Financials

Balance sheets

Sep 30, 2024Jun 30, 2024Mar 31, 2024Dec 31, 2023Sep 30, 2023Jun 1, 2023Mar 1, 2023Dec 1, 2022Sep 1, 2022

Total Assets

$10.5 M(+17.5%)$8.9 M(-21.8%)$11.4 M(-3.6%)$11.8 M(-11.1%)$13.3 M(-3.9%)$13.8 M-$4.8 M-

Current Assets

$8.2 M(+25.9%)$6.5 M(-27.1%)$8.9 M(-3.2%)$9.2 M(-15.6%)$10.9 M(-7.2%)$11.8 M-$2.6 M-

Non Current Assets

$2.3 M(-5.5%)$2.4 M(-3.0%)$2.5 M(-5.0%)$2.6 M(+9.3%)$2.4 M(+14.4%)$2.1 M-$2.2 M-

Total Liabilities

$7.7 M(-31.6%)$11.3 M(-26.0%)$15.3 M(+44.4%)$10.6 M(+282.8%)$2.8 M(+10.8%)$2.5 M-$8.8 M-

Current Liabilities

$6.7 M(-34.1%)$10.1 M(-27.6%)$14.0 M(+52.3%)$9.2 M(+598.9%)$1.3 M(+39.5%)$942.0 K-$7.1 M-

Long Term Liabilities

$1.1 M(-9.6%)$1.2 M(-8.6%)$1.3 M(-7.8%)$1.4 M(-4.3%)$1.4 M(-6.6%)$1.5 M-$1.7 M-

Shareholders Equity

$2.7 M(+214.7%)-$2.4 M(+38.2%)-$3.9 M(-408.3%)$1.3 M(-88.1%)$10.5 M(-7.2%)$11.4 M--$4.0 M-

Book Value

$2.7 M(+214.7%)-$2.4 M(+38.2%)-$3.9 M(-408.3%)$1.3 M(-88.1%)$10.5 M(-7.2%)$11.4 M--$4.0 M-

Working Capital

$1.5 M(+142.0%)-$3.6 M(+28.4%)-$5.1 M(-15921.9%)$32.0 K(-99.7%)$9.6 M(-11.3%)$10.8 M--$4.4 M-

Cash And Cash Equivalents

$7.8 M(+31.0%)$6.0 M(-26.8%)$8.2 M(-11.0%)$9.2 M(-14.9%)$10.8 M(-5.4%)$11.4 M-$2.3 M-

Accounts Payable

$1.2 M(-2.4%)$1.2 M(+48.4%)$814.0 K(-43.6%)$1.4 M(+76.1%)$820.0 K(+37.1%)$598.0 K-$758.0 K-

Accounts Receivable

---------

Short Term Debt

$507.0 K(-24.2%)$669.0 K(-19.5%)$831.0 K(+129.6%)$362.0 K(+2.5%)$353.0 K(+2.6%)$344.0 K-$5.8 M-

Long Term Debt

$1.1 M(-9.6%)$1.2 M(-8.6%)$1.3 M(-7.8%)$1.4 M(-4.3%)$1.4 M(-6.6%)$1.5 M-$1.7 M-

Total Debt

$1.6 M(-14.9%)$1.8 M(-12.9%)$2.1 M(+20.7%)$1.7 M(-2.9%)$1.8 M(-4.9%)$1.9 M(+100.0%)$0.0(-100.0%)$7.5 M(+100.0%)$0.0

Debt To Equity

0.6(+174.0%)-0.8(-40.0%)-0.6(-139.6%)1.4(+717.6%)0.2(0%)0.2--1.9-

Current Ratio

1.2(+92.2%)0.6(0%)0.6(-36.0%)1.0(-88.0%)8.3(-33.4%)12.5-0.4-

Quick Ratio

---------

Inventory

---------

Retained Earnings

-$32.4 M(-1.6%)-$31.9 M(+2.7%)-$32.8 M(-34.7%)-$24.4 M(-66.4%)-$14.6 M(-17.6%)-$12.4 M--$7.9 M-

PB Ratio

37.7(+157.3%)-65.8(+28.1%)-91.6------

Income statements

Sep 30, 2024Jun 30, 2024Mar 31, 2024Dec 31, 2023Sep 30, 2023Jun 1, 2023Mar 1, 2023Dec 1, 2022Sep 1, 2022

EPS

-$0.0(-133.3%)$0.0(+111.1%)-$0.3(+9.8%)-$0.3(-343.3%)-$0.1(-1.5%)-$0.1(+56.7%)-$0.2(-227.5%)-$0.0(+2.5%)-$0.0

TTM EPS

-$0.5(+9.5%)-$0.6(+13.7%)-$0.7(-19.8%)-$0.6(-75.4%)-$0.3(-6.2%)-$0.3(-26.8%)-$0.2(-161.7%)-$0.1(-97.5%)-$0.0

Revenue

---------

TTM Revenue

---------

Total Expenses

$3.4 M(+4.0%)$3.2 M(-6.5%)$3.5 M(+39.1%)$2.5 M(+20.9%)$2.1 M(-2.0%)$2.1 M(-7.6%)$2.3 M(+73.7%)$1.3 M(-2.8%)$1.3 M

Operating Expenses

$3.4 M(+4.0%)$3.2 M(-6.5%)$3.5 M(+39.1%)$2.5 M(+20.9%)$2.1 M(-2.0%)$2.1 M(-7.6%)$2.3 M(+73.7%)$1.3 M(-2.8%)$1.3 M

Cost Of Goods Sold

---------

TTM Cost Of Goods Sold

---------

Gross Profit

---------

TTM Gross Profit

---------

Gross Margin

---------

Operating Profit

-$3.4 M(-4.0%)-$3.2 M(+6.5%)-$3.5 M(-39.1%)-$2.5 M(-20.9%)-$2.1 M(+2.0%)-$2.1 M(+7.6%)-$2.3 M(-73.7%)-$1.3 M(+2.8%)-$1.3 M

TTM Operating Profit

-$12.5 M(-11.6%)-$11.2 M(-11.2%)-$10.1 M(-13.3%)-$8.9 M(-15.3%)-$7.7 M(-10.2%)-$7.0 M(-42.6%)-$4.9 M(-85.6%)-$2.6 M(-97.2%)-$1.3 M

Operating Margin

---------

Net Income

-$500.0 K(-155.7%)$898.0 K(+110.6%)-$8.5 M(+12.9%)-$9.7 M(-343.1%)-$2.2 M(-1.5%)-$2.2 M(+10.6%)-$2.4 M(-58.5%)-$1.5 M(+2.4%)-$1.6 M

TTM Net Income

-$17.8 M(+8.7%)-$19.5 M(+13.6%)-$22.5 M(-36.7%)-$16.5 M(-98.8%)-$8.3 M(-8.2%)-$7.7 M(-39.3%)-$5.5 M(-78.3%)-$3.1 M(-97.6%)-$1.6 M

Net Margin

---------

EBIT

-$495.0 K(-154.8%)$903.0 K(+110.7%)-$8.5 M(+13.0%)-$9.7 M(-343.1%)-$2.2 M(-2.0%)-$2.1 M(+5.7%)-$2.3 M(-74.8%)-$1.3 M(+2.8%)-$1.3 M

TTM EBIT

-$17.8 M(+8.7%)-$19.5 M(+13.6%)-$22.5 M(-37.8%)-$16.3 M(-106.1%)-$7.9 M(-12.0%)-$7.1 M(-43.6%)-$4.9 M(-86.2%)-$2.6 M(-97.2%)-$1.3 M

EBITDA

-$352.0 K(-133.8%)$1.0 M(+112.5%)-$8.3 M(+13.2%)-$9.6 M(-360.6%)-$2.1 M(-1.5%)-$2.1 M(+6.1%)-$2.2 M(-80.5%)-$1.2 M(+9.8%)-$1.3 M

TTM EBITDA

-$17.2 M(+9.1%)-$18.9 M(+14.0%)-$22.0 M(-38.6%)-$15.9 M(-111.3%)-$7.5 M(-10.9%)-$6.8 M(-43.3%)-$4.7 M(-85.6%)-$2.6 M(-90.2%)-$1.3 M

Selling, General & Administrative Expenses

$2.1 M(-4.9%)$2.2 M(-9.7%)$2.5 M(+45.9%)$1.7 M(+15.3%)$1.5 M(-4.2%)$1.5 M(-13.5%)$1.8 M(+86.3%)$959.0 K(-3.4%)$993.0 K

TTM SGA

$8.6 M(+8.3%)$7.9 M(+9.7%)$7.2 M(+10.8%)$6.5 M(+13.0%)$5.8 M(+9.2%)$5.3 M(+41.4%)$3.7 M(+91.5%)$2.0 M(+96.6%)$993.0 K

Depreciation And Amortization

$143.0 K(+2.1%)$140.0 K(+2.2%)$137.0 K(+5.4%)$130.0 K(+16.1%)$112.0 K(+13.1%)$99.0 K(+3.1%)$96.0 K-$0.0

TTM D&A

$550.0 K(+6.0%)$519.0 K(+8.6%)$478.0 K(+9.4%)$437.0 K(+42.4%)$307.0 K(+57.4%)$195.0 K(+103.1%)$96.0 K-$0.0

Interest Expense

$5000.0(0%)$5000.0(+25.0%)$4000.0(+300.0%)$1000.0(+100.0%)$0.0(-100.0%)$10.0 K(-92.6%)$135.0 K(-38.6%)$220.0 K(-0.5%)$221.0 K

TTM Interest Expense

$15.0 K(+50.0%)$10.0 K(-33.3%)$15.0 K(-89.7%)$146.0 K(-60.0%)$365.0 K(-37.7%)$586.0 K(+1.7%)$576.0 K(+30.6%)$441.0 K(+99.5%)$221.0 K

Income Tax

---------

TTM Income Tax

---------

PE Ratio

---------

PS Ratio

---------

Cashflow statements

Sep 30, 2024Jun 30, 2024Mar 31, 2024Dec 31, 2023Sep 30, 2023Jun 1, 2023Mar 1, 2023Dec 1, 2022Sep 1, 2022

Cash From Operations

-$2.6 M(-33.9%)-$1.9 M(+54.5%)-$4.3 M(-167.0%)-$1.6 M(-40.6%)-$1.1 M(+29.9%)-$1.6 M(+20.2%)-$2.0 M--$2.9 M

TTM CFO

-$10.4 M(-16.4%)-$9.0 M(-3.7%)-$8.6 M(-35.0%)-$6.4 M(-33.4%)-$4.8 M(+26.8%)-$6.6 M(-33.0%)-$4.9 M--$2.9 M

Cash From Investing

-$11.0 K(+83.3%)-$66.0 K(-725.0%)-$8000.0(-300.0%)-$2000.0(+99.5%)-$413.0 K(-1620.8%)-$24.0 K(+57.1%)-$56.0 K-$0.0

TTM CFI

-$87.0 K(+82.2%)-$489.0 K(-9.4%)-$447.0 K(+9.7%)-$495.0 K(-0.4%)-$493.0 K(-516.3%)-$80.0 K(-42.9%)-$56.0 K-$0.0

Cash From Financing

$4.5 M(+2699.4%)-$172.0 K(-105.3%)$3.3 M(+100.0%)$0.0(-100.0%)$940.0 K(+154.9%)-$1.7 M(-111.8%)$14.6 M-$3.8 M

TTM CFF

$7.6 M(+87.3%)$4.0 M(+61.5%)$2.5 M(-81.8%)$13.8 M(0%)$13.8 M(-17.1%)$16.6 M(-9.3%)$18.3 M-$3.8 M

Free Cash Flow

-$2.6 M(-30.0%)-$2.0 M(+53.0%)-$4.3 M(-167.2%)-$1.6 M(-3.3%)-$1.6 M(+5.9%)-$1.6 M(+21.2%)-$2.1 M--$2.9 M

TTM FCF

-$10.5 M(-11.3%)-$9.5 M(-4.0%)-$9.1 M(-31.8%)-$6.9 M(-30.3%)-$5.3 M(+20.2%)-$6.6 M(-33.1%)-$5.0 M--$2.9 M

CAPEX

---------

TTM CAPEX

---------

Dividends Paid

---------

TTM Dividends Paid

---------

TTM Dividend Per Share

---------

TTM Dividend Yield

---------

Payout Ratio

---------